RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02255435 |
Recruitment Status :
Active, not recruiting
First Posted : October 2, 2014
Last Update Posted : October 12, 2020
|
Sponsor:
Reata Pharmaceuticals, Inc.
Collaborators:
AbbVie
Friedreich's Ataxia Research Alliance
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | October 3, 2019 |
Estimated Study Completion Date : | December 2022 |
Certification/Extension First Submitted : | October 1, 2020 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):